Leaflet LOPINAVIR/RITONAVIR ACCORD 200mg / 50mg film-coated tablets

Product code:
W63612002
Quantity:
120
Indicated for:
HIV-1 infection
Route of administration:
oral
Substance:
lopinavir + ritonavir (protease inhibitors)
ATC
J05AR10 — Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Precautions:

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Lopinavir + ritonavir is a combination medication used for the treatment of human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and is used to reduce the viral load in the body, helping to delay disease progression and maintain immune system function.

- Lopinavir is the main active agent that inhibits HIV protease, an enzyme essential for viral replication.
- Ritonavir is used in low doses to boost lopinavir levels in the blood by inhibiting its metabolism in the liver (boosting effect).

This combination is administered as tablets or oral solution, usually twice daily, in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART).

Side effects may include nausea, diarrhea, abdominal pain, fatigue, increased cholesterol and triglyceride levels, and changes in liver function. In rare cases, it may cause pancreatitis or severe allergic reactions. It is important to take the medication as prescribed by a doctor, and patients should be regularly monitored to assess treatment effectiveness and prevent adverse effects.

General data about LOPINAVIR/RITONAVIR ACCORD 200mg / 50mg

Substance:
lopinavir + ritonavir
Date of latest medicines list:
01-03-2022
Product code:
W63612002
Concentration:
200mg / 50mg
Pharmaceutical form:
film-coated tablets
Quantity:
120
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PHARMADOX HEALTHCARE LTD. - MALTA
Holder:
ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
Number:
14542/2022/01
Shelf life:
2 years

Pharmaceutical forms available for lopinavir + ritonavir

Concentrations available for lopinavir + ritonavir

  • 100mg/25mg
  • 133.3mg/33.3mg
  • 200mg/50mg
  • 80mg/20mg/ml